According to the most recent financial data from March 2025, the EPS for the trailing twelve months is $9.97. Cme Group's EPS for 2024 amounted to $9.69, marking an increase from $8.87 in 2023. During the quarterly period ending on Mar 31, 2025, CME's EPS stood at $2.63.
Cme Group had an annual EPS of $9.69, indicating an increase of 9.2% from $8.87 in 2023. The quarterly per-share earnings for the period ending Mar 31, 2025, was $2.63, indicating a 11.9% increase from the same quarter last year. CME's 12-month EPS stands at $9.97 as of March 2025. Cme Group's annual EPS in 2023 stood at $8.87, a 19.7% increase year-over-year.
During the last 12 months, Cme Group has seen an EPS growth of 11.9% (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of 9.9% per year for the last three years. During the last 5 years, the company had an average EPS growth rate of 10.3%. A 10-year view shows that CME has seen an average EPS growth of 11.1% per year.
Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
---|---|---|---|---|
CME Cme Group Inc | 27.51 | 9.2% | 9.9% | 10.3% |
CBOE Cboe Global Markets Inc | 29.1 | 1.1% | 13.7% | 16.7% |
ICE Intercontinental Exchange Inc | 36.84 | 14.3% | -12.7% | 6.9% |
NDAQ Nasdaq Inc | 38.39 | -7.6% | -6.6% | 4.5% |
MSCI MSCI Inc | 39 | -2.5% | 17% | 16.2% |
All data is based on quarterly TTM periods, unless otherwise specified.